Lars Linderoth
13Patents
7h-index
15Co-inventors
55Inventor score
Filing activity: Dec 16, 2010 → Nov 22, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8648041B2 | Double-acylated GLP-1 derivatives | Physics | 26 | Active |
| US9266940B2 | Double-acylated GLP-1 derivatives | Human Necessities | 24 | Active |
| US10005827B2 | Double-acylated GLP-1 derivatives | Human Necessities | 22 | Active |
| US8815802B2 | GLP-1 analogues and derivatives | Physics | 18 | Active |
| US9527900B2 | Double-acylated GLP-1 derivatives | Human Necessities | 17 | Active |
| US9006178B2 | Double-acylated GLP-1 derivatives with a linker | Human Necessities | 16 | Active |
| US9708383B2 | Double-acylated GLP-1 derivatives | Human Necessities | 10 | Active |
| US10689429B2 | Double-acylated GLP-1 compounds | Human Necessities | 5 | Active |
| US11117947B2 | Double-acylated GLP-1 derivatives | Human Necessities | 5 | Active |
| US11034746B2 | Double-acylated GLP-1 derivatives | Human Necessities | 4 | Active |
| US9556250B2 | Double-acylated GLP-1 derivatives | Physics | 2 | Active |
| US10946074B2 | GLP-1 derivatives and uses thereof | Human Necessities | 2 | Active |
| US10822385B2 | EGF(A) analogues with fatty acid substituents | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.